RAPT
USDRAPT Therapeutics Inc. Common Stock
实时价格
价格图表
关键指标
市场指标
开盘价
$28.550
最高价
$29.605
最低价
$28.190
成交量
0.43M
公司基本面
市值
708.8M
所属行业
生物技术
国家/地区
United States
交易统计
平均成交量
0.36M
交易所
NGM
货币
USD
52周价格范围
相关新闻
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing
Wells Fargo Maintains Overweight on RAPT Therapeutics, Raises Price Target to $72
Wells Fargo analyst Yanan Zhu maintains RAPT Therapeutics with a Overweight and raises the price target from $48 to $72.
HC Wainwright & Co. Maintains Buy on RAPT Therapeutics, Raises Price Target to $72
HC Wainwright & Co. analyst Emily Bodnar maintains RAPT Therapeutics with a Buy and raises the price target from $27 to $72.
Guggenheim Initiates Coverage On RAPT Therapeutics with Buy Rating, Announces Price Target of $70
Guggenheim analyst Yatin Suneja initiates coverage on RAPT Therapeutics with a Buy rating and announces Price Target of $70.
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT) ("RAPT"), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and
Wells Fargo Maintains Overweight on RAPT Therapeutics, Raises Price Target to $48
Wells Fargo analyst Yanan Zhu maintains RAPT Therapeutics with a Overweight and raises the price target from $38 to $48.
Barclays Maintains Overweight on RAPT Therapeutics, Raises Price Target to $58
Barclays analyst Etzer Darout maintains RAPT Therapeutics with a Overweight and raises the price target from $35 to $58.
